Insulin Pump Therapy Insurance Claim Denied? How to Appeal

Insulin pump therapy — continuous subcutaneous insulin infusion (CSII) — is the standard of care for Type 1 diabetes management and is increasingly used for insulin-requiring Type 2 diabetes. Modern automated insulin delivery (AID) systems like the Tandem t:slim X2 with Control-IQ, Omnipod 5, and Medtronic MiniMed 780G integrate with continuous glucose monitors to automatically adjust insulin delivery. Despite robust clinical evidence and ADA guideline support, insulin pump claims are denied frequently due to documentation deficiencies or insurer criteria that diverge from current clinical standards.

Why Insurers Deny Insulin Pump Therapy

Not medically necessary — "adequate control on MDI." The insurer claims multiple daily injection therapy is sufficient. The ADA Standards of Medical Care 2024 and the ATTD Consensus recommend AID systems as the standard of care for T1D, citing consistent evidence of improved Time in Range (TIR), reduced hypoglycemia (30–50% reduction), and quality of life benefits over MDI.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained or expired. Insulin pump and CSII coverage requires prior authorization that must be renewed periodically. An administrative authorization failure — whether on the physician's side or the DME supplier's side — results in denial even where the clinical indication is unambiguous.

Type 1 diabetes not adequately documented. Medicare and many commercial plans require specific documentation of T1D — C-peptide level ≤0.5 ng/mL (or ≤110% of the lower limit of normal for the laboratory) and a qualifying diagnosis. GAD or IA-2 antibody testing may also be required. Missing lab values are a leading cause of technically correctable denials.

Step therapy — MDI not documented as inadequate. Insurers typically require documentation of 3–6 months of MDI therapy with inadequate control (A1c above target, frequent hypoglycemia, or hypoglycemia unawareness) before approving CSII. If this documentation is absent, the denial may be technically correct — but if the clinical record exists, it needs to be compiled and submitted.

Hypoglycemia unawareness not documented. Many CPBs require documented hypoglycemia unawareness (inability to recognize warning signs of low blood sugar) as a separate criterion for pump approval. This must be clinically assessed and documented by the endocrinologist.

Hybrid closed-loop classified as experimental. Older CPBs may still classify AID/closed-loop systems as investigational despite FDA clearance. This is directly challengeable with current FDA clearance documentation and ADA guideline citations.

How to Appeal an Insulin Pump Denial

Step 1: Request the insurer's Clinical Policy Bulletin

Ask the insurer in writing for the CPB or coverage determination for insulin pump/CSII. This document lists every criterion you must meet — it becomes your appeal roadmap. Address each criterion point by point in your appeal.

Step 2: Compile all required clinical documentation

Gather: diabetes type documentation (C-peptide level, antibody testing); A1c history over 12–24 months; glucose log or CGM data documenting hypoglycemic episodes (values < 70 mg/dL) or elevated A1c on MDI; endocrinologist documentation of hypoglycemia unawareness if applicable; documentation of MDI regimen (number of injections per day, doses); and any prior CSII trials or training completion.

Step 3: Obtain your endocrinologist's targeted letter of medical necessity

The letter must address each of the insurer's specific denial criteria. For medical necessity: cite ADA Standards of Medical Care 2024, which recommend AID systems as the standard of care for T1D, and ATTD Consensus on TIR targets. Document specific episodes of hypoglycemia, A1c trends, and why CSII is medically necessary for this specific patient. If hypoglycemia unawareness is present, document it explicitly with clinical history.

Step 4: Invoke Medicare DME criteria if applicable

For Medicare Part B appeals: submit the C-peptide level meeting the ≤110% threshold, endocrinologist documentation of medical necessity, and evidence of inadequate control on MDI. Medicare Part B covers insulin pumps as DME when these criteria are documented.

Step 5: Challenge step therapy requirements with AID evidence

If the denial cites incomplete step therapy, compile the MDI history: regimen, doses, duration, A1c values, hypoglycemic episodes, and reason for escalation. If the endocrinologist determined that MDI is inherently inadequate for this patient (e.g., due to hypoglycemia unawareness), this is a medical necessity argument that step therapy should be bypassed.

Step 6: File for External Independent Review: Complete Guide" class="auto-link">external review if internal appeal fails

Under the ACA, independent external review is available for DME and medical necessity denials at no cost. For Medicare, the five-level appeals process (redetermination, QIC reconsideration, ALJ hearing, Medicare Appeals Council, federal court) provides multiple escalation opportunities.

What to Include in Your Appeal

• C-peptide level and diabetes type documentation (T1D or insulin-requiring T2D confirmation)
• Endocrinologist letter citing ADA Standards 2024 and addressing each CPB criterion
• A1c history and glucose log or CGM data demonstrating inadequate control on MDI
• Hypoglycemia documentation — specific episodes with dates, blood glucose values, and clinical context
• Hypoglycemia unawareness assessment if the insurer's criteria require it
• FDA clearance documentation for the specific AID/closed-loop system if classified as experimental

Fight Back With ClaimBack

Insulin pump denials turn on specific clinical criteria — C-peptide thresholds, MDI failure documentation, and hypoglycemia unawareness. ClaimBack generates a professional appeal letter in 3 minutes that directly addresses these criteria. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal